Grantham, Mayo, Van Otterloo & Co (GMO)

Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings

AUM $35.4B
1-Year Est. Return 17.05%
This Quarter Est. Return
1 Year Est. Return
+17.05%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$31.7B
AUM Growth
+$976M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
683
New
Increased
Reduced
Closed

Top Buys

1
+$328M
2
+$325M
3
+$253M
4
TMO icon
Thermo Fisher Scientific
TMO
+$180M
5
USB icon
US Bancorp
USB
+$129M

Top Sells

1
+$129M
2
+$128M
3
+$90.4M
4
GSK icon
GSK
GSK
+$78M
5
DGX icon
Quest Diagnostics
DGX
+$44.4M

Sector Composition

1 Technology 29.69%
2 Healthcare 26%
3 Financials 11.57%
4 Communication Services 9.28%
5 Consumer Discretionary 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
626
– –
-3,278
627
– –
-412,722
628
– –
-5,241
629
– –
-42,784
630
– –
-2,684
631
– –
-355,500
632
– –
-275,937
633
– –
-21,300
634
– –
-5,252
635
– –
-227,181
636
– –
-43,272
637
– –
-27,913
638
– –
-13,251
639
– –
-10,310
640
– –
-566,121
641
– –
-2,498
642
– –
-151,153
643
– –
-980
644
– –
-66,583
645
– –
-42,866
646
– –
-13,539
647
– –
-16,687
648
– –
-9,716
649
– –
-7,648
650
– –
-11,404
24 25
26
27 28